benzoxazoles has been researched along with Lupus Erythematosus, Systemic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bucala, R; Chen, D; Fu, Q; Huang, H; Leng, L; Li, J; Lu, L; Pu, J; Ye, S; Yuan, A | 1 |
Dou, H; Fan, H; Hou, Y; Li, X; Pan, Y; Ren, J; Shi, G; Zhang, X | 1 |
2 other study(ies) available for benzoxazoles and Lupus Erythematosus, Systemic
Article | Year |
---|---|
The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
Topics: Adult; Animals; Benzoxazoles; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Female; Fibrosis; Humans; Intramolecular Oxidoreductases; Lupus Erythematosus, Systemic; Macrophage Migration-Inhibitory Factors; Male; Mice, Inbred C57BL; Middle Aged; Mitogen-Activated Protein Kinases; Myocytes, Smooth Muscle; Pulmonary Arterial Hypertension; Pulmonary Artery | 2019 |
mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus.
Topics: Animals; Benzoxazoles; Cells, Cultured; Female; Inflammasomes; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lupus Nephritis; Macrophages; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pyrimidines; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |